Assessment by a double Randomization of a Conventional antiplatelet strategy versus a monitoring-guided strategy for drug-eluting stent implantation and, of Treatment Interruption versus Continuation one year after stenting - ARCTIC-INTERRUPTION


The goal of the trial was to evaluate treatment with 1 year of dual antiplatelet therapy compared with 2 years of therapy among patients who received a drug-eluting stent.